From December 14 to 17, 2025, the Marriott Marquis San Diego will host the Antibody Engineering & Therapeutics conference, a premier event for antibody and protein innovation. This in-person event is expected to bring together leading scientists, executives, and industry exhibitors to discuss breakthrough topics such as bispecifics, ADCs (antibody-drug conjugates), and antibody-based therapies for cancer and neurodegenerative diseases.

In 2024, the conference attracted over 100 world-class speakers, including Jo Viney from Seismic Therapeutic, James A. Wells from UCSF, Ray Deshaies from Amgen, and Erica Ollmann Saphire from the La Jolla Institute for Immunology. The event featured over 60 scientific posters highlighting cutting-edge research and early keynotes for 2025 have already been confirmed. The conference is designed to provide attendees with a comprehensive understanding of the latest advancements in antibody science and their commercial potential.

The conference offers a unique opportunity for exhibitors to showcase their technologies to a highly technical and specific audience. According to Michael Kierny from AstraZeneca, "The Global AET conferences have become a staple event for us as a great opportunity to showcase our technologies to a large, highly technical and specific audience." The Antibody Society supports these events by providing educational webinars and symposia, serving as the home for the AIRR (Adaptive Immune Receptor Repertoire) Community, and engaging with international agencies on matters important to the antibody community.

Attendees can explore pioneering innovations in antibody-based degraders, bispecifics and multi-specific antibodies, ADCs, and unconventional formats such as single-domain antibodies. The conference also delves into therapeutic applications of these innovations in metabolic and neurodegenerative diseases, autoimmune diseases, cancer treatment, and more. With its focus on reverse translation medicine and cutting-edge techniques like phage display and cell-free systems, this event is essential for staying at the forefront of antibody science.

If you missed out on last year's event or are looking to expand your network within the antibody engineering community, this is your chance to relive key moments through highlights videos or register your interest for next year's conference. The Antibody Engineering & Therapeutics conference continues to be a leading meeting shaping the future of antibody science.